Embecta Aktie News

SAN DIEGO, 03. Juli 2026 (GLOBE NEWSWIRE) -- Robbins LLP erinnert Aktionäre daran, dass eine Sammelklage im Namen aller Investoren eingereicht wurde, die zwischen dem 25. November 2025 und dem 4. Mai 2026 Wertpapiere von Embecta Corp. (NASDAQ: EMBC) erworben oder anderweitig erworben haben. Embecta ist ein Medizintechnikunternehmen, das Lösungen zur Verbesserung der Gesundheit und des Wohlbefin...

LOS ANGELES, June 29, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of EMBC during the class period...

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities fraud class action has been filed in the United States District Court for the District of New Jersey on behalf of investors who purchased or acquired shares of Embecta Corp. (NASDAQ: EMBC) (“Embecta” or the “Company”) between November 25, 2025 to May 4, 2026, inclusive.   In...

LOS ANGELES, June 25, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of EMBC during the class period...

LOS ANGELES--(BUSINESS WIRE)---- $EMBC--Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – EMBC.

PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that Nimish Muzumdar has been named the company's Senior Vice President and President, North America, effective June 15, 2026.

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.